A recent
report published by Infinium Global Research on the helicobacter pylori (H. Pylori)
non-invasive testing market provides an in-depth analysis of segments and
sub-segments in the global as well as regional helicobacter pylori (H. Pylori)
non-invasive testing market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional helicobacter pylori
(H. Pylori) non-invasive testing market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecasts, and dollar
values of the global helicobacter pylori (H. Pylori) non-invasive testing market.
According to the report, the global helicobacter pylori (H. Pylori) non-invasive
testing market is projected to grow at a CAGR of 4.2% over the forecast period
of 2019-2025.
Helicobacter
pylori is a gram-negative spiral bacterium found in the stomach. helicobacter
pylori comprise of a large diversity of strains, and hundreds of genomes that
are entirely sequenced. helicobacter pylori infection is diagnosed by invasive
techniques such as endoscopy and biopsy. There are non-invasive techniques
involved, they are the urea breath test, serology, urine detection, and blood detection
for helicobacter pylori and its antigen in stool. Non-invasive test is further
classified into active and passive infection testes. The urea breath test and
stool antigen tests are active infection tests. Serology, urine detection, and
blood detection are passive tests. The urea breath test has high accuracy as
compared to serology and antigen stool tests.
The rising
prevalence of infections occurring through helicobacter pylori and awareness
against the same is driving the helicobacter pylori non-invasive testing
market. Helicobacter pylori are contagious, it is spread through the oral-oral
route or fecal-oral route. Although the exact route of transmission is not
known. Globally, 10% of children and 80% of adults are likely to have helicobacter pylori infection. Rising Governments are taking initiatives for
the eradication of Helicobacter pylori and thereby eliminating the risk of
gastric cancer. Additionally, non-invasive techniques are available easily and
they are cost-effective. This leads to the growth of the helicobacter pylori
non-invasive testing market. In Helicobacter pylori infection, the diagnosis
rates are very low and the occurrence of infection is high. In most the cases, the bacteria do not
show any symptoms and it goes undiagnosed. The emergence of home diagnostic kits
for helicobacter pylori infection is providing the opportunity for the growth
of the helicobacter pylori non-invasive testing market.
Amongst the Geographies, North America is holding the major market share in the Helicobacter pylori (H. Pylori) non-invasive testing market. The growing prevalence of Helicobacter pylori infection is boosting the growth of the Helicobacter pylori non-invasive testing market. North America has the highest the aging population which increases the demand for diagnosis. Further, leading to the growth of the Helicobacter pylori non-invasive testing market in this region. Europe holds the second largest market share in the growth of the Helicobacter pylori non-invasive testing market due to an increase in companies investing in the non-invasive diagnosis of Helicobacter pylori infection. The Asia Pacific is estimated to be the fastest growing region for the Helicobacter pylori non-invasive testing market. This is by adopting new technologies in the market and the rising population exposed to infections in this region. Additionally, the growing healthcare sector in this region is boosting the growth of the Helicobacter pylori non-invasive testing market.
-non-invasive-testing-market.jpg)
The report on
global Helicobacter pylori (h. pylori) non-invasive testing market covers
segments such as test type, test method, and end-user. On the basis of test
type, the sub-markets include serology test, and stool antigen test. On the
basis of test method, the sub-markets include laboratory based tests, and
point-of-care tests. On the basis of end-user, the sub-markets include
hospitals, and clinics.
The report
provides profiles of the companies in the market such as Thermo Fisher
Scientific, Meridian Bioscience, Inc., Shenzhen Zhonghe Headway Bio-Sci &
Tech Co., Ltd., DiaSorin S.p.A., Exalenz Bioscience Ltd., Certest Biotec S.L.,
CorisBioconcept SPRL, Sekisui Diagnostics, and Biomerica, Inc.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of Helicobacter pylori (H. Pylori) non-invasive testing market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.